In the present research, similarly to that occurring with IL-1β at 4 h after transplantation, supplying a NO donor at the same dose in both liver types led to different results: NO donor was beneficial in non-steatotic livers but resulted in detrimental effects in the presence of steatosis. The gene discussed is IL1B; the disease is steatosis.